AQR Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

AQR Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,633	Closed	-$565K	–	2284
2020 Q3	$565K	Sell	13,633 -6,151	-31%	-$283K	﹤0.01%	1668
2020 Q2	$948K	Buy	19,784 +1,415	+8%	+$109K	﹤0.01%	1481
2020 Q1	$1.16M	Sell	18,369 -1,983	-10%	-$178K	﹤0.01%	1281
2019 Q4	$2.52M	Sell	20,352 -4,218	-17%	-$378K	﹤0.01%	1183
2019 Q3	$1.63M	Sell	24,570 -7,934	-24%	-$533K	﹤0.01%	1362
2019 Q2	$2.59M	Sell	32,504 -3	-0%	-$269	﹤0.01%	1184
2019 Q1	$3.64M	Buy	32,507 +211	+0.7%	+$23.1K	﹤0.01%	1100
2018 Q4	$3.25M	Buy	32,296 +10,419	+48%	+$1.08M	﹤0.01%	1078
2018 Q3	$2.76M	Buy	+21,877	New	+$2.32M	﹤0.01%	1250
2016 Q1	–	Sell	-9,247	Closed	-$1.38M	–	2301
2015 Q4	$1.38M	Buy	+9,247	New	+$1.57M	﹤0.01%	1435
2015 Q3	–	Sell	-3,999	Closed	-$965K	–	2282
2015 Q2	$965K	Buy	3,999 +799	+25%	+$213K	﹤0.01%	1508
2015 Q1	$902K	Sell	3,200 -3,700	-54%	-$801K	﹤0.01%	1465
2014 Q4	$1.08M	Sell	6,900 -17,700	-72%	-$3.27M	﹤0.01%	1609
2014 Q3	$5.82M	Buy	24,600 +16,757	+214%	+$4.27M	0.02%	767
2014 Q2	$1.86M	Buy	7,843 +2,700	+52%	+$712K	0.01%	1324
2014 Q1	$1.7M	Sell	5,143 -1,600	-24%	-$540K	0.01%	1403
2013 Q4	$460K	Buy	+6,743	New	+$390K	﹤0.01%	2108
2013 Q3	–	Sell	-25,000	Closed	-$1.12M	–	2552
2013 Q2	$1.12M	Buy	+25,000	New	+$854K	﹤0.01%	1517

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

AQR Capital Management's ICPT Position: Q4 2020 in Review

AQR Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 13,633 shares — an estimated $565K sold.

AQR Capital Management first reported a position in ICPT in Q2 2013 and held it in 18 quarters. The position peaked at $5.82M in Q3 2014. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

AQR Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
AQR Capital Management sold 13,633 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $565K.
AQR Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
AQR Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $5.82M in Q3 2014.
175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.